Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-026290)

Filing Details

Accession Number:: 0001181431-13-026290
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-08 17:53:59
Reporting Period:: 2013-05-06

Filing Date:: 2013-05-08
Accepted Time:: 2013-05-08 17:53:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1016169	Antares Pharma Inc.	ATRS	Surgical & Medical Instruments & Apparatus (3841)	411350192

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1054942	F Robert Apple	C/O Antares Pharma, Inc. 100 Princeton South, Suite 300 Ewing NJ 08628	Executive Vice President & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-05-06	10,000	$0.47	311,578	No	4	M	Direct
Common Stock	Disposition	2013-05-06	10,000	$4.02	301,578	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	STOCK OPTION (RIGHT TO BUY)	Disposition	2013-05-06	10,000	$0.00	10,000	$0.47

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,201,158		2018-11-12	No	4	M	Direct

Footnotes

The stock option exercises and sales of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The options vested in equal quarterly installments over three years following the grant date.